FDA Import Refusal 112-6095832-2/2/1 — Glaxo Smith Kline
The FDA refused shipment 112-6095832-2/2/1 from Glaxo Smith Kline (United States) on Mar 6, 2012. The refused product falls under Drugs and Biologics — CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 6, 2012
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61XBA45 CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC)
- Charges
- 75